What is the current stock price of NovelStem International Corp. (NSTM)?

As of the latest market data, NovelStem International Corp. (NSTM) is trading at $0.01. The stock has seen a loss of 0.00% today.

Does NovelStem International Corp. (NSTM) pay a dividend?

Based on current data, NovelStem International Corp. does not have a confirmed active dividend policy.

What is the market cap of NovelStem International Corp.?

The current market capitalization of NovelStem International Corp. (NSTM) is approximately unavailable.

NSTM

NovelStem International Corp.·Healthcare

0.01

0.000%(+0.00)

Close Price

Last Updated: — ET

52W L: $0.0152W H: $0.04

NSTM NEWS

defenseworld.net

Mar 6

NovelStem International (OTCMKTS:NSTM) and Halozyme Therapeutics (NASDAQ:HALO) Head to Head Contrast

NovelStem International (OTCMKTS:NSTM - Get Free Report) and Halozyme Therapeutics (NASDAQ: HALO - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Volatility and Risk NovelStem International has a beta

Company Profile

NovelStem International Corp. focuses on developing and commercialization of diagnostic technology for cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was founded in 1993 and is headquartered in Boca Raton, Florida.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

1993-11-12

Beta

2.26

Websitewww.novelstem.com↗